- Investing Ideas
- /
- Italian Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Italian Pharmaceuticals & Biotech Strong Balance Sheet Stocks
UPDATED Mar 17, 2023
U.S. Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
6 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ABSArterra Bioscience | €2.32 | -5.7% | 10.5% | €15.4m | n/a | PE11x | n/a | 2.2% | ||
| SHEShedir Pharma Group | €3.91 | 2.9% | 2.4% | €44.7m | €7.62 | PE10.6x | E15.8% | 3.3% | ||
| PRLPierrel | €0.18 | -2.7% | -11.3% | €41.2m | n/a | PE36.5x | E74.3% | n/a | ||
| PHILPhilogen | €15.48 | 0.5% | 17.3% | €450.8m | €19.00 | PS19.4x | E8.5% | n/a | ||
| FCMFriulchem | €1.07 | -4.5% | 0.9% | €6.4m | €1.50 | PE52.2x | E77.3% | n/a | ||
| UBMUlisse Biomed | €2.44 | -3.0% | 3.6% | €19.7m | €1.65 | PS43.8x | E86.4% | n/a |
Page 1 of 1